Companies that are inventing incredibly important drugs go down almost every day.
In tech, several of these tropes are currently making the rounds.
See: yesterday's rapid lockstep reversal.
Until these overpriced stocks come down enough to attract acquirers, I think they'll cause real problems for the market.
It's unnerving that almost every strong stock has a poorly performing company underneath it.
It's very easy to stand by. Maybe too easy.
In a world where folks are afraid of their own shadow, Jamie Dimon's incisive letter should urge you to take more risk.
That's the takeaway from the Alcoa call, which gave us its most bullish worldview since the Great Recession ended.
But in the real world they're wrong, as the Questcor buyout demonstrates.
The nasty decline in momentum names can't be dismissed as something based on fundamentals.